Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01985945 · ClinicalTrials.gov registry record · NA

Yoga for Breast Cancer

A NA study, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT01985945: Completed NA study, sponsored by Abramson Cancer Center at Penn Medicine.

NCT01985945 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01985945, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive therapy, Questionnaire measuring cancer-related quality of life (FACT-G instrument) and fatigue (Brief Fatique Inventory) will be given to patients at several points.

Interventions

  • OTHER Yoga

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2013-03
Est. Completion 2015-12-31
Phase NA

What the finished NCT01985945 record still lists

NCT01985945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Yoga is the first listed.

NCT01985945 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01985945 about?

NCT01985945 is a clinical study titled "Yoga for Breast Cancer". The purpose of this study is to examine the use of Eischens yoga for 8 weeks in one cohort of 20 women with stage I and II breast cancer receiving radiation therapy treatment, while a second cohort of the same type of and number of patients who, instead of yoga will receive standard supportive thera...

What is the current status of trial NCT01985945?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-03. Estimated completion is 2015-12-31.

What interventions are being tested in trial NCT01985945?

The interventions under investigation include: Yoga (OTHER).

Who is sponsoring clinical trial NCT01985945?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01985945's enrollment target sits among peer trials

70 1103rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01985945, the US trial registry maintained by the National Library of Medicine. NCT01985945 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.